Key Insights

Highlights

Success Rate

99% trial completion (above average)

Published Results

16 trials with published results (13%)

Research Maturity

73 completed trials (59% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.8%

1 terminated out of 123 trials

Success Rate

98.6%

+12.1% vs benchmark

Late-Stage Pipeline

15%

19 trials in Phase 3/4

Results Transparency

22%

16 of 73 completed with results

Key Signals

16 with results99% success

Data Visualizations

Phase Distribution

98Total
Not Applicable (52)
P 1 (21)
P 2 (6)
P 3 (9)
P 4 (10)

Trial Status

Completed73
Unknown28
Not Yet Recruiting7
Recruiting5
Withdrawn5
Active Not Recruiting3

Trial Success Rate

98.6%

Benchmark: 86.6%

Based on 73 completed trials

Clinical Trials (123)

Showing 20 of 20 trials
NCT06961019Not ApplicableCompletedPrimary

Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients

NCT07654374Phase 3Not Yet Recruiting

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

NCT06497842Not ApplicableActive Not RecruitingPrimary

Effort During Resistance Training in Type 2 Diabetes

NCT07619157Phase 1RecruitingPrimary

A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus

NCT03313752Phase 3CompletedPrimary

Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity

NCT07203677CompletedPrimary

Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)

NCT07355270Not ApplicableRecruitingPrimary

A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)

NCT05457088Not ApplicableCompletedPrimary

High Protein Effect on Body Composition and Sarcopenia Markers in Older Patients With Type 2 Diabetes Mellitus

NCT07533604Not ApplicableRecruitingPrimary

SnapDandCGMinType2Diabetes

NCT00690326Not ApplicableCompleted

Behavioral Change Communication for Physical Activity Among Females With Type2 Diabetes Mellitus

NCT07188571Completed

Observational Study on GER in Patients With Simple Obesity

NCT07352618Not ApplicableEnrolling By InvitationPrimary

"Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus."

NCT07330700Not ApplicableCompletedPrimary

Effects of Marching Exercise With Cognitive Training on Physical, Cognitive Function, and Autonomic Cardiovascular Responses in Older Adults With Type 2 Diabetes Mellitus

NCT07296211Not ApplicableNot Yet RecruitingPrimary

INcreasing the Uptake of DSMES Program and Addressing Social Needs in Low-Income VulneRablE Immigrants

NCT03647306Not ApplicableActive Not RecruitingPrimary

Behavioral Chronotype: Impact on Sleep and Metabolism

NCT03527277Not ApplicableCompleted

Orange Juice And Sugar Intervention Study

NCT06257966Phase 3Active Not RecruitingPrimary

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

NCT07169786Not Yet Recruiting

Diet and Progression of CKD in Patients With Type 2 Diabetes Mellitus

NCT04481997CompletedPrimary

Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI

NCT07044765Phase 1Not Yet RecruitingPrimary

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Scroll to load more

Research Network

Activity Timeline